Whole grain guidance
This article was originally published in The Tan Sheet
Executive Summary
Claims on whole grain products should not imply a "particular level of the ingredient" such as "high" or "excellent source," FDA says in whole grain label statements draft guidance published in the Feb. 17 1Federal Register. Manufacturers may make factual statements such as "100% whole grain" or "10 grams of whole grains" and may use heart disease/certain cancer risk reduction health claims for qualifying foods, according to the draft. The agency defines which grains and forms qualify as whole grains in the document. Comments on the draft are due April 18...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.